<PAGE>
EXHIBIT 99.1
JOINT FILING AGREEMENT
The undersigned hereby agree that the Statement on Schedule 13D, dated
November 13, 2000, (the "Schedule 13D"), with respect to the Common Stock, $0.01
par value, of Tutogen Medical, Inc. is, and any amendments thereto executed by
each of us shall be, filed on behalf of each of us pursuant to and in accordance
with the provisions of Rule 13d-1(k) (1) (iii) under the Securities and Exchange
Act of 1934, as amended, and that this Agreement shall be included as an Exhibit
to the Schedule 13D. Each of the undersigned agrees to be responsible for the
timely filing of the Schedule 13D and any amendments thereto, and for the
completeness and accuracy of the information concerning itself contained
therein. This Agreement may be executed in any number of counterparts, all of
which taken together shall constitute one and the same instrument.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of
the 4th day of January, 2001.
SULZER AG
By: /s/ Roman Beran
-------------------------------------------
Name: Roman Beran
Title: Deputy Vice President and General Counsel,
Head of Legal Department
By: /s/ Kurt Haegi
-------------------------------------------
Name: Kurt Haegi
Title: Secretary General
SULZER MEDICA LTD.
By: /s/ Andre Buchel
-------------------------------------------
Name: Andre Buchel
Title: President and Chief Executive Office
By: /s/ Vanessa Oelz
-------------------------------------------
Name: Vanessa Oelz
Title: Secretary General
SULZER MEDICA USA HOLDING CO.
By: /s/ David S. Wise
-------------------------------------------
Name: David S. Wise
Title: Secretary
